Literature DB >> 4005798

Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer.

H H Gallion, J R van Nagell, E S Donaldson, M B Hanson, D E Powell, Y Maruyama, J Yoneda.   

Abstract

Seventy-five patients with bulky barrel-shaped Stage IB cervical cancers, treated at the University of Kentucky from 1965 to 1981, were the subjects of this investigation. Thirty-two of these patients were treated with radiation therapy alone and 43 were treated with radiation followed by extra-fascial hysterectomy. There were no significant differences in age, gravidity, or tumor cell type between the two treatment groups. Patients were seen at regular intervals from 2 to 11 years after treatment and none were lost to follow-up. Recurrent cancer was noted in 47% of patients treated by radiation alone as compared to 16% of those treated with combined therapy (P less than 0.01). The incidence of pelvic recurrence was reduced from 19% to 2% and extrapelvic recurrence from 16% to 7% in patients treated by combination therapy. No rectal or urinary tract fistulae were noted after extra-fascial hysterectomy. The findings of this study suggest that the use of extra-fascial hysterectomy following radiation therapy in patients with bulky Stage IB cervical cancer causes a significant reduction in tumor recurrence without producing an increase in treatment-related complications.

Entities:  

Mesh:

Year:  1985        PMID: 4005798     DOI: 10.1002/1097-0142(19850715)56:2<262::aid-cncr2820560210>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer.

Authors:  C A Chen; T M Chen; C C Wu; C F Chang; C Y Hsieh
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

2.  Experience in stage IB2 cervical cancer and review of treatment.

Authors:  Taner Turan; Burcu Aykan Yıldırım; Gökhan Tulunay; Nurettin Boran; Ferah Yıldız; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-03-01

Review 3.  Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.

Authors:  Vivek Nama; Georgios Angelopoulos; Jeremy Twigg; John B Murdoch; Jo Bailey; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2018-10-12

4.  Preoperative external beam radiotherapy and reduced dose brachytherapy for carcinoma of the cervix: survival and pathological response.

Authors:  Alexandre A Jacinto; Marcus S Castilho; Paulo E R S Novaes; Pablo R Novick; Gustavo A Viani; João V Salvajoli; Robson Ferrigno; Antonio Cássio A Pellizzon; Stella S S Lima; Maria A C Maia; Ricardo C Fogaroli
Journal:  Radiat Oncol       Date:  2007-02-22       Impact factor: 3.481

5.  Primary radical hysterectomy vs chemoradiation for IB2-IIA cervical cancer: A systematic review and meta-analysis.

Authors:  Ruo-Nan Yan; Zhen Zeng; Fang Liu; Yuan-Yuan Zeng; Tao He; Zhong-Zheng Xiang; Bai-Lu Zhang; Han-Lin Gong; Lei Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

6.  Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy.

Authors:  T Ota; N Takeshima; T Tabata; K Hasumi; K Takizawa
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.